文献速递细菌感染、耐药与抗菌药物新发突发、热带与寄生虫病

COVID-19患者抗生素处方率的快速综述与荟萃分析

Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis.
PubMed 文献 · Clin Microbiol Infect · 2021-01-05

BACKGROUND: The proportion of patients infected with SARS-CoV-2 that are prescribed antibiotics is uncertain, and may contribute to patient harm and global antibiotic resistance.…

要点

  • COVID-19患者抗生素处方合并患病率为74.6%,远高于估计的细菌合并感染率8.6%。
  • 儿童抗生素处方率低于成人(OR 0.10,95%CI 0.03-0.33)。
  • 抗生素处方随年龄增长(每增加10岁OR 1.45)和机械通气比例增加(每增加10% OR 1.33)而升高。

核心结论

  • 约四分之三的COVID-19患者接受抗生素处方,处方率显著高于估计的细菌合并感染率,不必要抗生素使用可能较高。

研究设计与样本

  • 快速综述与荟萃分析,检索MEDLINE、OVID Epub和EMBASE截至2020年6月9日的英文文献。
  • 纳入随机对照试验、队列研究、≥10例的病例系列及评估抗生素处方的实验或观察性设计研究。

主要发现

  • 抗生素处方合并患病率为74.6%(95%CI 68.3-80.0%)。
  • 儿童抗生素处方率低于成人(处方患病比数比OR 0.10,95%CI 0.03-0.33)。
  • 抗生素处方随患者年龄增加而升高(每增加10岁OR 1.45,95%CI 1.18-1.77)。
  • 抗生素处方随需要机械通气患者比例增加而升高(每增加10% OR 1.33,95%CI 1.15-1.54)。
  • 来自31项研究的估计细菌合并感染率为8.6%(95%CI 4.7-15.2%)。

关键数值与推荐

  • 估计细菌合并感染率8.6%(95%CI 4.7-15.2%),基于31项研究。
  • 儿童相对成人的抗生素处方OR为0.10(95%CI 0.03-0.33)。
  • 年龄每增加10岁的抗生素处方OR为1.45(95%CI 1.18-1.77)。
  • 机械通气患者比例每增加10%的抗生素处方OR为1.33(95%CI 1.15-1.54)。

临床怎么用

  • 应意识到COVID-19患者抗生素处方率远高于细菌合并感染估计率,需审慎评估抗生素使用指征。
  • 对儿童、高龄及接受机械通气比例较高的患者群体,应结合细菌感染证据决定是否处方抗生素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The proportion of patients infected with SARS-CoV-2 that are prescribed antibiotics is uncertain, and may contribute to patient harm and global antibiotic resistance. OBJECTIVE: The aim was to estimate the prevalence and associated factors of antibiotic prescribing in patients with COVID-19. DATA SOURCES: We searched MEDLINE, OVID Epub and EMBASE for published literature on human subjects in English up to June 9 2020. STUDY ELIGIBILITY CRITERIA: We included randomized controlled trials; cohort studies; case series with ≥10 patients; and experimental or observational design that evaluated antibiotic prescribing. PARTICIPANTS: The study participants were patients with laboratory-confirmed SARS-CoV-2 infection, across all healthcare settings (hospital and community) and age groups (paediatric and adult). METHODS: The main outcome of interest was proportion of COVID-19 patients prescribed an antibiotic, stratified by geographical region, severity of illness and age. We pooled proportion data using random effects meta-analysis. RESULTS: We screened 7469 studies, from which 154 were included in the final analysis. Antibiotic data were available from 30 623 patients. The prevalence of antibiotic prescribing was 74.6% (95% CI 68.3-80.0%). On univariable meta-regression, antibiotic prescribing was lower in children (prescribing prevalence odds ratio (OR) 0.10, 95% CI 0.03-0.33) compared with adults. Antibiotic prescribing was higher with increasing patient age (OR 1.45 per 10 year increase, 95% CI 1.18-1.77) and higher with increasing proportion of patients requiring mechanical ventilation (OR 1.33 per 10% increase, 95% CI 1.15-1.54). Estimated bacterial co-infection was 8.6% (95% CI 4.7-15.2%) from 31 studies. CONCLUSIONS: Three-quarters of patients with COVID-19 receive antibiotics, prescribing is significantly higher than the estimated prevalence of bacterial co-infection. Unnecessary antibiotic use is likely to be high in patients with COVID-19.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Langford BJ, So M, Raybardhan S, et al. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect. 2021. PMID: 33418017. doi:10.1016/j.cmi.2020.12.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。